诱导多能干细胞促进了癌症疫苗的开发和评估
Yuewen Zhai1, Xinyu Xu2, Ji Fang1
1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, China.
Cancer research
|August 6, 2024
概括
诱导多能干细胞 (iPSCs) 由于其独特的抗原,为通用癌症疫苗开发提供了一个有希望的途径. 它们还作为免疫细胞和瘤模型的来源,有助于疫苗研究和评估.
科学领域:
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 癌症疫苗旨在增强抗原特异性免疫反应.
- 诱导多能干细胞 (iPSCs) 具有内在的抗原表位,使其适合于通用疫苗策略.
- iPSCs可以分化为各种细胞类型,包括抗原呈现细胞和瘤有机体.
研究的目的:
- 审查iPSCs对疫苗开发的具体贡献.
- 在这种情况下,要总结iPSC的发展轨迹.
- 讨论在疫苗开发中应用iPSC的挑战和潜在解决方案.
主要方法:
- 文献综述,重点关注癌症疫苗研究中的iPSC应用.
- 对与疫苗生产相关的iPSC分化途径的分析.
- 确定临床翻译的障碍,并提出解决方案.
主要成果:
- iPSCs为开发通用癌症疫苗提供了一个可再生的来源.
- 差异化的iPSC可以产生抗原呈现细胞,用于基于免疫细胞的疫苗.
- 来自iPSC的瘤器官有助于癌症疫苗的测试和优化.
结论:
- iPSCs代表了一种用于推进癌症疫苗技术的多功能平台.
- 克服目前的应用障碍可以释放iPSCs在免疫治疗中的全部潜力.
- 对iPSC分化和免疫性进行进一步的研究对于临床成功至关重要.
相关概念视频
01:06Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:27Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K